LEAH Labs YCアプリケーション

Winter 2019Active

LEAH LabsはWinter 2019バッチでHealthcare企業としてY Combinatorを卒業しました。以下：会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。

YCバッチ: Winter 2019
業界: HealthcareTherapeutics
チーム規模: 4
ステータス: Active
ローンチ済み: 2018

創業者

Wesley WiersonFounder

LEAH Labsの事業内容

LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective "full stack" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.

LEAH LabsのYCアプリケーション、再構築済み

Y Combinator 申請

LEAH Labs 様、Winter 2019 バッチ。公開データから回答された、実際のフォームの質問。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

LEAH Labs

Describe what your company does in 50 characters or less.

Living therapies for pets first, people next

What is your company going to make? Please describe your product and what it does or will do.

We are building virus-free CAR-T cell therapies specifically for dogs with B cell lymphoma. Our product engineers living therapeutic cells that induce remission in pets, and we plan to extend this platform to human treatments later. The platform is designed to be cost-effective and usable by general practice veterinarians, expanding access to curative therapies outside specialty clinics.

Where do you live now, and where would the company be based after YC?

We currently live and work in Minneapolis, MN, and the company will remain based there after YC.

Explain your decision regarding location.

Minneapolis has strong biotech resources and because our founders are here, it's practical and cost-effective to stay. Being under USDA regulation rather than FDA lets us iterate faster even from this location.

フルアプリケーションで21件の追加回答

はフルバージョンにあります。無料アカウントを作成して、他のすべてのYCバッチの横にあるYCインサイトで開いてください。

申請内容全体を見る

よくある質問

LEAH Labsの実際のYCアプリケーションですか？

いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、LEAH Labsの公開データ（ローンチノート、創業者経歴、製品説明）から回答しています。LEAH Labsのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。